Milestone Pharmaceuticals (MIST) EPS (Basic) Growth (1y) (2019 - 2022)
Milestone Pharmaceuticals (MIST) EPS (Basic) Growth (1y) (2019 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,151.81% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -4.90% |
| Jun 30, 2022 | -2,251.35% |
| Dec 31, 2021 | -36.67% |
| Sep 30, 2021 | 16.19% |
| Jun 30, 2021 | 103.51% |
| Mar 31, 2021 | 54.44% |
| Dec 31, 2020 | 74.51% |
| Sep 30, 2020 | 23.21% |
| Jun 30, 2020 | 49.10% |
| Mar 31, 2020 | 96.16% |
| Dec 31, 2019 | 96.19% |
| Sep 30, 2019 | 97.40% |
| Jun 30, 2019 | 91.85% |
| Mar 31, 2019 | -11.32% |